160 related articles for article (PubMed ID: 31674066)
21. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
[TBL] [Abstract][Full Text] [Related]
22. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection.
Moore GW
Int J Lab Hematol; 2014 Jun; 36(3):364-73. PubMed ID: 24750683
[TBL] [Abstract][Full Text] [Related]
23. Laboratory identification of lupus anticoagulants.
Kershaw G; Suresh S; Orellana D; Nguy YM
Semin Thromb Hemost; 2012 Jun; 38(4):375-84. PubMed ID: 22573409
[TBL] [Abstract][Full Text] [Related]
24. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests?
Devreese KM
Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615
[No Abstract] [Full Text] [Related]
25. Screening coagulation testing using the APTT: which reagent to choose?
Dembitzer FR; Suarez Y; Aledort LM; Peerschke EI
Am J Hematol; 2010 Sep; 85(9):726. PubMed ID: 20645431
[TBL] [Abstract][Full Text] [Related]
26. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity.
Matsumoto T; Nogami K; Shima M
Int J Hematol; 2017 Feb; 105(2):174-183. PubMed ID: 27730530
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic methodologies for circulating anticoagulants.
Exner T
Thromb Haemost; 1995 Jul; 74(1):338-44. PubMed ID: 8578481
[TBL] [Abstract][Full Text] [Related]
28. Should healthy children who will undergo minor surgery be screened for coagulation disorder?
Kang S; Yoon HS; Lee EH
Pediatr Hematol Oncol; 2016 May; 33(4):233-8. PubMed ID: 27166650
[TBL] [Abstract][Full Text] [Related]
29. Inhibitor Index in the Clot Waveform Analysis-Based Mixing Test Differentiates among Hemophilia A without and with Inhibitors, and Lupus Anticoagulant.
Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Emmi M; Shima M; Nogami K
Thromb Haemost; 2021 Jun; 121(6):792-799. PubMed ID: 33412612
[TBL] [Abstract][Full Text] [Related]
30. Evaluating laboratory approaches to the identification of lupus anticoagulants: a diagnostic challenge from the RCPA Haematology QAP.
Bonar R; Favaloro E; Zebeljan D; Rosenfeld D; Kershaw G; Mohammed S; Marsden K; Hertzberg M
Pathology; 2012 Apr; 44(3):240-7. PubMed ID: 22183703
[TBL] [Abstract][Full Text] [Related]
31. Conceptions and misconceptions in testing for lupus anticoagulants.
Exner T
J Autoimmun; 2000 Sep; 15(2):179-83. PubMed ID: 10968906
[TBL] [Abstract][Full Text] [Related]
32. An improved method for lupus anticoagulant detection.
Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
[TBL] [Abstract][Full Text] [Related]
33. In vitro differential inhibition of the factor XI activity assay in the setting of a lupus anticoagulant.
Rabichow L; Dinh J; Nguyen L; Qiao J
Blood Coagul Fibrinolysis; 2024 Jun; 35(4):217-222. PubMed ID: 38358905
[TBL] [Abstract][Full Text] [Related]
34. MIXCON-LA: a precise, sensitive and specific aPTT-based assay for detection of lupus anticoagulant.
Lindhoff-Last E; Humpich M; Schmitt J; Rödiger S; Seifried E; Bauersachs R
Clin Appl Thromb Hemost; 2002 Apr; 8(2):163-7. PubMed ID: 12121058
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a modified procedure for Staclot LA for the confirmation of lupus anticoagulants.
Charles LA; McGlasson DL; Hawksworth BA; Ashcraft JH; Ortel TL
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):601-4. PubMed ID: 7841317
[TBL] [Abstract][Full Text] [Related]
36. [Mixing test for prolonged clotting time: clinical availability and problems].
Uchiba M; Ando Y
Rinsho Byori; 2009 Oct; 57(10):1004-12. PubMed ID: 19928499
[TBL] [Abstract][Full Text] [Related]
37. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Drews RE
Clin Chest Med; 2003 Dec; 24(4):607-22. PubMed ID: 14710693
[TBL] [Abstract][Full Text] [Related]
38. Pseudopathologies of hemostasis and dental surgery.
Capitanio AM; Sacco R; Mannucci PM
Oral Surg Oral Med Oral Pathol; 1991 Feb; 71(2):184-6. PubMed ID: 1825867
[TBL] [Abstract][Full Text] [Related]
39. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
[TBL] [Abstract][Full Text] [Related]
40. Reference interval mean clotting times should not be used to calculate lupus anticoagulant mixing test ratios unless they match the normal pooled plasma clotting time.
Moore GW
Thromb Res; 2017 Nov; 159():16-18. PubMed ID: 28946004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
